fasting treatment
英 [ˈfɑːstɪŋ ˈtriːtmənt]
美 [ˈfæstɪŋ ˈtriːtmənt]
网络 艾伦氏疗法; 艾伦疗法; 禁食疗法
双语例句
- Fasting makes early postmortem muscle shear force values have an increasing tendency, but the differences between treatment groups were not significant.
禁食使得宰后早期肌肉剪切力值有增大趋势，但处理组之间差异不显著。 - All patients were fasting, gastrointestinal decompression, somatostatin, parenteral nutrition support basic therapy, Treatment group plus aescine sodium.
两组均采用禁食、胃肠减压、生长抑素、肠外营养等支持基础疗法，治疗组另给予七叶皂苷钠。 - The Correlation of Tongue with Fasting Blood Glucose in Type 2 Diabetes Qi and Yin Deficiency and Blood Stasis Block Syndrome before and after Treatment
2型糖尿病气阴两虚兼血瘀证治疗前后舌色与空腹血糖等变化的相关性研究 - All of them were measured weight, fasting blood glucose ( FBG), fasting serum insulin ( FIN), blood lipid spectrum, HbA 1C, liver and kidney function before and after treatment.
对照组保持原治疗。分别测定用药前后体重、空腹血糖（FBG）、空腹胰岛素（FIN）、糖化血红蛋白（HbA1C）、血脂及肝、肾功能等。 - With regard to reducing fasting and postprandial blood glucose levels, the total effective rate in treatment group was 87% and 90% respectively, while in control group was 70% and 84%.
降低空腹、餐后血糖的总有效率治疗组分别为87%和90%，对照组分别为70%和84%。 - Methods: To compare and analyze microdosis urinary albumin ( Alb), fasting blood glucose ( FBG) and blood pressure before and after treatment.
方法：采用前后对照方法，分别检测治疗前后尿微量白蛋白（Alb）、空腹血糖（FBG）及血压进行比较分析。 - The fasting plasma insulin of the obstructive sleep apnea-hypopnea syndrome group was higher than the control group, and the insulin sensitivity index was lower, but after treatment, the fasting plasma insulin was decreased and insulin sensitivity index was elevated.
治疗组空腹胰岛素较对照组高，胰岛素敏感指数降低，在治疗后空腹胰岛素水平降低，而胰岛素敏感指数提高。 - The levels of serum TC, triglyceride, fasting insulin and fasting blood glucose were detected at 3 months after treatment.
治疗3个月后血清总胆固醇、三酰甘油、空腹胰岛素、空腹血糖水平。 - Fasting blood glucose ( FBG), GHbA 1c, plasma NO, PGI 2 and ET 1 were determined before and 12 wk after the treatment.
测定治疗前后空腹血糖（FBG）、糖化血红蛋白A1c（GHbA1c）及血浆NO、PGI2、ET-1水平。 - Method: 198 inpatients with schizophrenia were divided randomly into chlorpromazine group and risperidone group. HbA1C and fasting plasma glucose were tested before treatment and at 1,2,3,6,12 month after treatment, and compared with clinical routine fasting plasma glucose test.
方法：对198例单用氯丙嗪或利培酮治疗的精神分裂症住院患者于治疗前、治疗1、2、3、6、12个月测定HbA1C及血糖浓度并与常规血糖检测指标进行比较。 - Fasting urinary Ca/ Cr and serum alkaline phosphatase ( ALP) concentration were measured before and after treatment in all subjects.
两组均连续服用4周期，于用药前后分别测定血碱性磷酸酶（ALP）及尿Ca／Cr比值。 - Then the fasting insulin ( Ins) and blood sugar ( FBS) in venous blood were detected in the morning before and after the treatment, and the resistance of insulin was reflected by insulin sensitive index ( ISI).
于治疗前、后采取清晨空腹静脉血检测胰岛素（Ins）、血糖（FBS），胰岛素抵抗用胰岛素敏感指数（ISI）反映。 - Main efficacy parameters were the changes in fasting and postprandial blood glucose concentrations as well as in HbA-( 1C) levels after acarbose treatment.
主要的疗效参数是阿卡波糖治疗后空腹和餐后血糖水平的变化以及HbA（IC）水平的变化。 - Fasting blood glucose, blood lipid, blood creatinine, uric acid, blood potassium, blood natrium and blood chlorine, were examined before and after 2 months treatment.
治疗前和治疗后2个月后分别检测空腹血糖，血脂，血尿酸，血肌酐，血钾、钠和氯。 - Parameters of fasting blood sugar, blood lipids, hemorrheology level, 24 hours urinary albumin excretion and urine β 2-microglobulin were observed, measured, and then compared after and before treatment in two groups.
观测患者空腹血糖、血脂、血液流变学、24小时尿蛋白排泄率、尿β2-微球蛋白等指标，分别比较两组治疗前后及两组治疗后上述指标的变化情况。 - The changes of blood pressure, left ventricular weight index ( LVWI), fasting blood glucose ( FBG) and fasting insulin before and after treatment were compared.
比较治疗前后血压、左心室重量指数（LVWI）、空腹血糖、空腹胰岛素的变化。 - Furthermore, plasma glucose area under curve/ 24 hours, mean daily plasma glucose and fasting serum insulin levels between these two groups were also not statistically different, indicating that the efficacy of treatment was similar.
两组24h血糖曲线下面积，血糖日均值和空腹血清胰岛素水平也相近。 - Results: In treatment group, the level of fasting pancreatic glucagon ( PG) before treatment was ( 376 ± 29) pg/ mi and de-creased to ( 173 ± 22) pg/ ml after treatment ( P < 0. 001);
结果：治疗组空腹胰高糖素水平由治疗前（37±28）pg／ml降至治疗后的（173±22）pg／ml（P＜0.001）； - Conclusion The high risk patients should be taken comprehensive measures, including testing fasting blood glucose, lipid and weight period in treatment.
结论对高危患者采取综合措施，治疗期间应定期监测空腹血糖、血脂、体重等与糖代谢关系密切的指标。 - The results showed that fasting plasma NPY levels were higher in obese group than in control group before treatment.
结果显示，治疗前A、B两组NPY水平明显高于C组； - Methods 60 LADA patients were divided into GTT group and control group. Fasting C-peptide, GAD-Ab and insulin aute-antibodies ( IAA) were measured before and after 3 months GTT treatment.
方法60例LADA患者随机分为GTT组和对照组，应用GTT观察3个月前后空腹C肽、GAD-Ab和胰岛素抗体（IAA）的变化。 - Measurement of fasting total homocysteine serum level was performed after 6 months in short-term treatment group and control group.
短期治疗组接受HRT6个月后、对照组6个月后再测定空腹血清Hcy水平。 - We detected the fasting blood glucose, glycosylated hemoglobin, and morphologic changes in pancreas islet before and after treatment after 1 month. 2.
检测各组治疗前后空腹血糖、糖化血红蛋白，并观察治疗后胰岛形态学变化。 - Monitor changes in blood pressure during treatment, determination of fasting blood glucose and fasting insulin before and after the treatment, calculated insulin sensitivity index.
治疗期间监测血压变化，治疗前后测定空腹血糖，空腹胰岛素，计算胰岛素敏感指数。